For Healthcare Professionals Control hypersecretion... with Sandostatin LAR® Depot
Sandostatin (octreotide acetate) for Acromegaly
Sandostatin (octreotide acetate) for Acromegaly
Control the 'Critical 4'

Only Sandostatin LAR® Depot treats the 'Critical 4': control of hypersecretion at the site of the tumor where hormone overproduction starts, control of GH, control of IGF-1, and control of symptoms.
Sandostatin (octreotide acetate) for Carcinoid Syndrome
Sandostatin (octreotide acetate) for Carcinoid Syndrome
Targeted Therapy to Control the Symptoms

Sandostatin LAR® Depot targets the underlying causes of the symptoms, rather than simply masking them.
Adjust Text Size of Sandostatin LAR Depot (octreotide acetate)Small Text for Sandostatin LAR Depot (octreotide acetate)Medium Text for Sandostatin LAR Depot (octreotide acetate)Large Text for Sandostatin LAR Depot (octreotide acetate)
Reimbursement

Make reimbursement as hassle-free as possible with our Reimbursement Guide, find the codes and forms you need, and learn about Patient Assistance programs.

Mechanism of Action

Sandostatin LAR® Depot is a long-acting somatostatin analogue, and acts at the site of the tumor to inhibit hormone hypersecretion in acromegaly and carcinoid syndrome.

For questions about Novartis products

Search our database of medical publications, slide kits, and audio files.

Go to Novartis oncology medical services
US Sandostatin Home | For Healthcare Professionals
About Sandostatin | Acromegaly | Carcinoid Syndrome & VIPomas | Reimbursement & Acquisition | Resources
Prescribing Information | Important Information | Site Map | Contact Us | Sites For Patients: AcromegalyInfo.com | Carcinoid.com